Albumin-globulin ratio for prediction of long-term mortality in lung adenocarcinoma patients

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 15, 2014, Pages 6449-6453

  Duran, Ayse Ocak ^a   Inanc, Mevlude ^a   Karaca, Halit ^a   Dogan, Imran ^a   Berk, Veli ^a   Bozkurt, Oktay ^a   Ozaslan, Ersin ^a   Ucar, Mahmut ^a   Eroglu, Celalettin ^a   Ozkan, Metin ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Albumin globulin ratio; Lung adenocarcinoma; Survival

Indexed keywords

GLOBULIN; SERUM ALBUMIN; TUMOR MARKER;

ADENOCARCINOMA; BLOOD; CANCER STAGING; FEMALE; FOLLOW UP; HUMAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADENOCARCINOMA; BIOMARKERS, TUMOR; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GLOBULINS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SERUM ALBUMIN; SURVIVAL RATE;

EID: 84928892100     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.15.6449     Document Type: Article

References (29)

1. Andersen S, Eilertsen M, Donnem T, et al (2011). Diverging prognostic impacts of hypoxic markers according to NSCLC histology. Lung Cancer, 72(3): 294-302.
2. Azab B, Kedia S, Shah N, et al (2013). The value of the pretreatment albumin/globulin ratio in predicting the longterm survival in colorectal cancer. Int J Colorectal Dis, 28, 1629-36.
3. Azab BN, Bhatt VR, Vonfrolio S, et al (2013). Value of the pretreatment albumin to globulin ratio in predicting long-term mortality in breast cancer patients. Am J Surg, 206, 764-70.
4. Canna K, McArdle PA, McMillan DC, et al (2005). The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer, 92, 651-4.
5. Cueto Manzano AM (2001). Hypoalbuminemia in dialysis. Is it a marker for malnutrition or inflammation? Rev Invest Clin, 53, 152-8.
6. Dai J, Tang K, Xiao W, et al (2014). Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis. Asian Pac J Cancer Prev, 15, 3369-75.
7. Du XJ, Tang LL, Mao YP, et al (2014). The Pretreatment albumin to globulin ratio has predictive value for long-term mortality in nasopharyngeal carcinoma. PLoS ONE, 9, e94473.
8. de Geus-Oei LF, van Krieken JH, Aliredjo RP, et al (2007). Biological correlates of FDG uptake in non-small cell lung cancer. Lung Cancer, 55, 79-87.
9. Gabay C, Kushner I. (1999). Acute-phase proteins and other systemic responses to inflammation. N Engl J Med, 340, 448-54.
10. Greene FL, Page DL, Fleming ID (2002). AJCC cancer staging manual.6th ed. New York: Springer-Verlag.
11. Guo YZ, Pan L, Du CJ, Ren DQ, Xie XM (2013). Association between C-reactive protein and risk of cancer: a metaanalysis of prospective cohort studies. Asian Pac J Cancer Prev, 14, 243-8.
12. Gupta D, Lis CG (2010). Pretreatment serum albumin as a predictor of cancersurvival: a systematic review of the epidemiological literature. Nutr J, 9, 69.
13. Jemal A, Siegel R, Xu J, Ward E (2010). Cancer statistics. CA Cancer J Clin, 60, 277-300.
14. Jin Y1, Zhao L, Peng F (2013). Prognostic impact of serum albumin levels on the recurrence of stage I non-small cell lung cancer. Clinics (Sao Paulo), 68, 686-93.
15. Kaya V, Yildirim M, Demirpence O, Yildiz M, Yalcin AY (2013) Prognostic significance of basic laboratory methods in nonsmall-cell-lung cancer. Asian Pac J Cancer Prev, 14, 5473-6.
16. Laky B, Janda M, Bauer J, et al (2007). Malnutrition among gynaecological cancer patients. Eur J Clin Nutr, 61, 642-6.
17. Laursen I, Briand P, Lykkesfeldt AE (1990). Serum albumin as a modulator on growth of the human breast cancer cell line, MCF-7. Anticancer Res, 10, 343-51.
18. Mantovani A, Allavena P, Sica A, Balkwill F (2008). Cancerrelated inflammation. Nature, 454, 436-44.
19. McMillan DC (2009). Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care, 12, 223-6.
20. McPherson R. Specific proteins. In: McPherson RA, Pincus MR, editors (2006). Henry's clinical diagnosis and management by laboratory methods. 21st ed. New York: Saunders.
21. Onate-Ocana LF, Aiello-Crocifoglio V, Gallardo-Rincon D, et al (2007). Serum albumin as a significant prognostic factor for patients with gastric carcinoma. Ann Surg Oncol, 14, 381-9.
22. Shimada H, Nabeya Y, Okazumi S, et al (2003). Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol, 83, 248-52.
23. Soliman NA, Keshk WA, Shoheib ZS, Ashour DS, Shamloula MM (2014). Inflammation, oxidative stress and L-fucose as indispensable participants in schistosomiasis-associated colonic dysplasia. Asian Pac J Cancer Prev, 15, 1125-31.
24. Song XY, Zhou SJ, Xiao N, et al (2013). Research on the relationship between serum levels of inflammatory cytokines and non-small cell lung cancer. Asian Pac J Cancer Prev, 14, 4765-8.
25. Sonnenschein C, Soto AM, Michaelson CL (1996). Human serum albumin shares the properties of estrocolyone-I, the inhibitor of the proliferation of estrogen-target cells. J Steroid Biochem Mol Biol, 59, 147-54.
26. Unal D, Eroglu C, Kurtul N, Oguz A, Tasdemir A (2013). Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis? Asian Pac J Cancer Prev, 14, 5237-42.
27. Yeun JY, Kaysen GA (1998). Factors influencing serum albumin in dialysis patients. Am J Kidney Dis, 32, 118-25.
28. Yildirim M, Yildiz M, Duman E, Goktas S, Kaya V (2013). Prognostic importance of the nutritional status and systemic inflammatory response in non-small cell lung cancer. J BUON, 18, 728-32.
29. Zheng YB, Zhao W, Liu B, et al (2013). The blood neutrophil-tolymphocyte ratio predicts survival in patients with advanced hepatocellular carcinoma receiving sorafenib. Asian Pac J Cancer Prev, 14, 5527-31.